The purpose of this program/presentation, sponsored by the Heart Rhythm Society, is to bring together leading cardiac care providers in a roundtable discussion to share their experiences and express their views regarding various possible appropriate courses of action to take in light of the recent announcements by Medtronic regarding their Sprint Fidelis defibrillation leads. It is the intention of the Society that relating specific patient experiences and sharing views and information about these leads generally, may be of benefit to you in your treatment of your individual patients. The views and opinions expressed by the participants in this program are their own, based upon their individual specific patient experiences or their general observations reacting to hypothetical circumstances. The views expressed and the statements made by participating physicians do not represent specific medical advice with respect to your patients nor do they represent any official policy or position taken by the Heart Rhythm Society. Consistent with the Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines (Adobe PDF document, 195K) published in September 2006, every patient/device situation is unique and appropriate medical decisions and course of treatment can only be made by the treating physician with his or her patient taking into consideration the specific facts and circumstances of that case.

The views expressed in this program are based upon the information that has been made available to date. The Society will continue to closely monitor the situation and will strive to keep its Members currently advised of any new developments which may cause the participants to change their views as expressed in this program.